Supplement monograph
SAMe
A mood and joint-positioned compound where antidepressant context, bipolar-risk screening, GI tolerance, and claim separation matter more than methylation marketing.
Practical read
Review mood history and medication context before any timing question. If a clinician supports use, keep dose, timing, and other mood-active products stable so effects and adverse signals are interpretable.
Decision frame
SAMe: what to check before it earns a slot
Timing rule
Review mood history and medication context before any timing question. If a clinician supports use, keep dose, timing, and other mood-active products stable so effects and adverse signals are interpretable.
Form lens
Safety lens
Best fit
- Mood-stack safety audits
- Joint-stack claim review
- Serotonergic-overlap screening
Form notes
- Enteric-coated tablets: common stability-focused format
- Mood blends: harder to attribute effects
- Joint blends: often mix several claims
Watchouts
- Antidepressants and other serotonergic medicines require clinician review
- Bipolar disorder or mania history is a high-caution context
- GI effects, anxiety, or insomnia can limit use
Sources and next checks
Evidence Brief
Get supplement timing and safety notes as they ship.
Monthly evidence briefs. No hype, no disease claims, no influencer supplement stacks.
These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Generated by AI. Always verify with a healthcare professional. Educational information only. Not a substitute for professional medical advice.